DOCSLIB.ORG

AMERSA) 125 Whipple Street, 3Rd Floor Providence, Rhode Island 02908

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
AMERSA) 125 Whipple Street, 3Rd Floor Providence, Rhode Island 02908 Strategic Plan for Interdisciplinary Faculty Development: Arming the Nation’s Health Professional Workforce for a New Approach to Substance Use Disorders Edited by MARY R. HAACK, PHD, RN, FAAN HOOVER ADGER, JR., MD, MPH Association for Medical Education and Research in Substance Abuse (AMERSA) 125 Whipple Street, 3rd Floor Providence, Rhode Island 02908 For more information: AMERSA Telephone: 401-349-0000 Fax: 877-418-8769 Web Sites: www.amersa.org and www.projectmainstream.net This publication has been produced by the Association for Medical Education and Research in Substance Abuse under a Cooperative Agreement (HRSA-#U78HP00001) with the Bureau of Health Professions, Health Resources and Services Administration (HRSA), in collaboration with the Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration (SAMHSA). The conclusions and opinions expressed herein are those of the authors and do not necessarily represent the views and policies of HRSA or of SAMHSA. September 2002 TABLE OF CONTENTS Table of Contents............................................................................................................................................................iii Contributors ....................................................................................................................................................................v Acknowledgments .........................................................................................................................................................vii Letter from the President of the Association for Medical Education and Research in Substance Abuse............................. viii Letter from the Project Director ..................................................................................................................................... ix Foreword........................................................................................................................................................................ x Executive Summary ........................................................................................................................................................ 1 Mary R. Haack, PhD, RN, FAAN, and Hoover Adger, Jr., MD, MPH Part I: Evidence Supporting the Strategic Plan Chapter 1. Prevention of Alcohol and Drug Abuse: What Works? .................................................................................. 25 Karol L. Kumpfer, PhD Chapter 2. Screening, Assessment, and Intervention for Substance Use Disorders in General Health Care Settings ............................................................................................................................. 47 Michael F. Fleming, MD, MPH Chapter 3. Is Addiction an Illness? Can It Be Treated? ................................................................................................... 67 A. Thomas McLellan, PhD Chapter 4. Medicaid Reimbursement of Primary Care Providers for Treatment of Substance Use Disorders ..................... 95 Mary R. Haack, PhD, RN, FAAN, and Farrokh Alemi, PhD Chapter 5. Substance Abuse in Older Adults: Review and Recommendations for Education and Practice in Medical Settings ........................................................................................................................... 105 Kristen Lawton Barry, PhD, Frederic C. Blow, PhD, and David W. Oslin, MD Chapter 6. Substance Use Disorders in Children and Adolescents and the Impact on Children in Families Affected by Substance Use .................................................................................................................. 133 Hoover Adger, Jr., MD, MPH, and Michelle K. Leff, MD Chapter 7. Recognizing and Treating Dual Diagnosis in General Health Care Settings: Core Competencies and How to Achieve Them.................................................................................................... 143 Kathleen T. Brady, MD, PhD Chapter 8. Impairment Issues for Health Care Professionals: Review and Recommendations ........................................ 155 Martha E. Brown, MD, Alison M. Trinkoff, RN, ScD, FAAN, Arden G. Christen, DDS, MSD, MA, and Ernest J. Dole, PharmD, FASHP, BCPS, CDE Part II: Discipline-Specific Recommendations for Faculty Development Chapter 1. The Role of Allied Health Professionals in Substance Abuse Education ........................................................ 169 John A. Bonaguro, PhD, PT, Ernie Nalette, EdD, PT, and Mary Lee Seibert, EdD Chapter 2. Dental Education in the Prevention and Treatment of Substance Use Disorders........................................... 185 Arden G. Christen, DDS, MSD, MA, and Joan A. Christen, BGS, MS Chapter 3. The Physician’s Role in Caring for Patients with Substance Use Disorders: Implications for Medical Education and Training .................................................................................................. 207 David A. Fiellin, MD, Richard Butler, DO, Gail D’Onofrio, MD, Richard L. Brown, MD, MPH, and Patrick G. O’Connor, MD iii Chapter 4. The Role of Midwives in Caring for Women with Substance Use Disorders: Implications for Training .......... 223 Pat Paluzzi, CNM, DrPH, Nicole Deggins, CNM, MSN, Ellen Hutchins, MSW, ScD, and Patricia Burkhardt, CNM, DrPH Chapter 5. Substance Abuse Education for Nurse Practitioners in Primary Care ........................................................... 235 Elias Vasquez, PhD, NNP, FAAN, and Marie Eileen Onieal, MMHS, RN, CPNP Chapter 6. Nursing Education in the Prevention and Treatment of Substance Use Disorders ......................................... 247 Madeline A. Naegle, RN, PhD, FAAN Chapter 7. Recommendations for Implementing Effective Substance Abuse Education in Pharmacy Practice................. 263 Ernest J. Dole, PharmD, PhC, FASHP, BCPS, CDE, and Anthony Tommasello, PhD Chapter 8. Improving Physician Assistant Education and Practice in Substance Use Disorders and Policy Recommendations on Substance Abuse Education for Physician Assistants .................................................. 273 Catherine R. Judd, MS, PA-C, Roderick Hooker, PhD, PA, and Perri Morgan, MS, PA-C Chapter 9. Educating Psychologists about Substance Abuse ......................................................................................... 289 William R. Miller, PhD Chapter 10. Incorporating Substance Abuse Prevention into Public Health Curricula ................................................... 305 Christopher L. Ringwalt, DrPH, MSW Chapter 11. Educating Social Workers to Work with Individuals Affected by Substance Use Disorders .......................... 319 Shulamith Lala Ashenberg Straussner, DSW, CAS, CEAP, and Evan Senreich, CSW, ACSW, CASAC Appendixes Appendix A: Acronyms ............................................................................................................................................... 341 Appendix B: Glossary .................................................................................................................................................. 345 iv CONTRIBUTORS Hoover Adger, Jr., MD, MPH Arden G. Christen, DDS, MSD, MA Associate Professor Department of Oral Biology School of Medicine School of Dentistry Johns Hopkins University Indiana University Baltimore, MD Indianapolis, IN Farrokh Alemi, PhD Joan Christen, BGS, MS School of Nursing and Health Services Department of Oral Biology Management School of Dentistry George Mason University Indiana University Fairfax, VA Indianapolis, IN Kristen Lawton Barry, PhD Nicole M. Deggins, CNM, MSN, MPH Department of Psychiatry University of Mississippi Medical Center University of Michigan Lexington, MS Ann Arbor, MI Ernest J. Dole, PharmD, PHC, FASHP, Frederic C. Blow, PhD BCPS, CDE Department of Psychiatry Lovelace Health Systems University of Michigan College of Pharmacy Ann Arbor, MI University of New Mexico Health and Sciences Center John Bonaguro, PhD Albuquerque, NM School of Health Sciences and Human Performance David A. Fiellin, MD Ithaca College Department of Internal Medicine Ithaca, NY Yale University School of Medicine New Haven, CT Kathleen Brady, MD, PhD Department of Psychiatry Michael Fleming, MD, MPH Medical University of South Carolina Family Medicine Research Program Charleston, SC University of Wisconsin Madison, WI Martha Brown, MD USF Psychiatry Center Mary R. Haack, PhD, RN, FAAN University of South Florida Department of Behavioral and Community Tampa, FL 33613 Health Nursing School of Nursing Richard L. Brown, MD, MPH University of Maryland Department of Family Medicine Baltimore, MD University of Wisconsin Madison, WI Roderick Hooker, PhD, PA Department of Physician Assistant Studies Patricia Burkhardt, CNM, DrPH University of Texas Southwestern Division of Nursing Medical Center New York University Dallas, TX New York, NY Ellen Hutchins, ScD, MSW Richard Butler, DO Women’s Health Branch Michigan State University College of Division of Perinatal Systems and Women’s Osteopathic Medicine Health Madison Heights, MI Maternal and Child Health Bureau Health Resources and Services Administration Rockville, MD v Catherine Judd, PA-C, MS David Oslin, MD Department of Physician Assistant Studies Department of Psychiatry University of Texas Allied Health Sciences University of Pennsylvania School Philadelphia, PA Desoto, TX Gail D’Onofrio, MD Karol Kumpfer, PhD Section of Emergency Medicine Department of Health Education Yale University University of Utah New Haven, CT Salt Lake City, UT Pat
Load more

Recommended publications
  • Alcohol and Drug Abuse in Medical Education. INSTITUTION State Univ
    Doman RESUME ED 192 216 CG 014 672 AUTHOR Galanter, Marc. Ed. TITLE Alcohol and Drug Abuse in Medical Education. INSTITUTION State univ. of New York, Brooklyn., Downstate Medical Center.: Yeshiva univ.. Bronx, N.Y. Albert Einstein Coll. of Medicine. PONS AGENCY National Inst. on Drug Abuse (DBZW/PHS), Rockville, Md. REPORT NO ADM-79 -891 PUP EATS SO GRANT TO1-DA-00083: T01-CA-00197 NOTE 128p. AVAILABLE Pint superintendent of Documents, O.S. Government Printing Office, Washington, DC 20402 EDES PRICE mF01/FC06 Plus Postage. DESCRIPTORS *Alcohol Education: *Drug Abuse: *Drug Education: Higher Education: *Medical Education: medical School Faculty; Medical Services; *Physician Patient Relationship: Physicians: *social Responsibility: State cf the Art Reviews ABSTRACT This book presents the state of the art of American medical education in alcohol and drug abuse,and is the culmination of a four-year collaborative effort among the medicalschool faculty, of the Career Teacher Program in Alcohol and DrugAbuse. The first part contains reports, curricula, andsurvey data prepared for the medical education community, focusingon drug abuse and alcoholism teaching in medical/osteopathic schools, icourse on alcoholism for physicians, the Career Teacher Program andResource Handbook, and the role of substance abuse attitudes in_treatment.The second part is-- the proceedings of the NationalConference on Medical Education and Drug Abuse, November 1977. The conference sessionsaddress issues such as: (1) the physician's role in substance abuse treatment;(2) physicians' use of drugs and alcohol:(3) drug abuse questions on the National Board Examinations: and (4)an overview of the Career Teacher Program activities. (Author/HLM) * *s * * * * * * * * * * * * * * ** ***************** * * * * ** * * * * * * * * * * * * * * * * * * * * * * * *0 Reproductions supplied by EDRS are the best thatcan be made from the original document.
    [Show full text]
  • Dwi Drug Court Intervention and Treatment Program
    DWI DRUG COURT INTERVENTION AND TREATMENT PROGRAM OPERATIONS MANUAL EL PASO, TEXAS TABLE OF CONTENTS Overview Page 1-3 Eligibility/disqualification criteria Page 4 Pre-qualification screenings/clinical assessment Page 4-5 Confidentiality/Consent for Release of Confidential Information Page 5-9 Program Phase Requirements Page 10-15 Incentives/Sanctions (Grid Tables) Page 16-23 Treatment Services Page 24-25 Supervision Protocol Page 26 Alcohol/Drug testing Protocol Page 27 Termination Criteria Page 27 Program Fees Page 27-28 Team Staffing Meetings Page 28 Data Collection and Program Evaluation Page 28-29 Team member roles Page 29-31 Team Member Departures and Replacement Page 32 Team Member Coverage Page 32 Use of DWI Drug Court Program Equipment Page 33 Equipment/Electronics Usage (Statement of Understanding) Page 34-35 SOP for Surveillance officers Page 36-41 Surveillance Report Form Page 42 Confidentiality Agreement Page 43-44 Participant’s Program Contract Page 45-55 Participant Program Handbook Page 56-74 1 FORWARD The policies and procedures, outlined in this manual, represent the minimum requirements of the DWI Drug Court Intervention and Treatment Program. Additionally, specific practices were developed to provide team guidance and encourage DWI Drug Court participant conformity. The structure of these policies and procedures will: • Creating public awareness through forums and informational meetings; • Minimize duplication of efforts and ensure greater coordination among all affected departments and agencies; • Maximize coordination and sharing of treatment resources; • Strengthen efforts to obtain funding; by periodically reviewing, monitoring, and • Managing data; furthermore to analyze program effectiveness, modified operations and refine goals. MISSION STATEMENT The mission of the DWI Drug Court Program is designed to reduce recidivism of alcohol and drug offenders and to enhance public safety through a cost effective integrated continuum of care and a judicially supervised regime of treatment and innovative case management.
    [Show full text]
  • Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction
    Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction A Treatment Improvement Protocol TIP 40 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES BP Substance Abuse and Mental Health Services Administration Buprenorphine Center for Substance Abuse Treatment Clinical Guide www.samhsa.gov BP Buprenorphine Clinical Guide Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction in the Treatment Clinical Guidelines for the Use of Buprenorphine TIP 40 Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction Laura McNicholas, M.D., Ph.D. Consensus Panel Chair A Treatment Improvement Protocol TIP 40 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment 1 Choke Cherry Road Rockville, MD 20857 Acknowledgments described in this document are intended or should be inferred. The guidelines in this Numerous people contributed to the document should not be considered development of this TIP (see pp. ix, xi, and substitutes for individualized client care and appendix J). This publication was produced treatment decisions. by the American Institutes for Research® (AIR) under the Center for Substance Abuse Treatment (CSAT) contract, task order Public Domain Notice number 277-00-6401 under the Substance All materials appearing in this volume except Abuse and Mental Health Services those taken directly from copyrighted sources Administration (SAMHSA) contract, Number are in the public domain and may be 277-99-6400, U.S. Department of Health and reproduced or copied without permission from Human Services (DHHS). CAPT Susanne SAMHSA/CSAT or the authors.
    [Show full text]
  • DWI COURTS Judge John “Kevin” Holbrook
    DWI COURTS Impaired Driving Case Essentials Honorable Michael Barrasse Honorable Peggy Fulton Hora Rhinestone Cowboy at .20 “Down and Out in Beverly Hills” “Rock Bottom” at .17 Brave(?) Mouth at .12 with prior “Baby Love” at .20 Objectives Overview of NCDC/DWI Drug Court Model Federally funded DWI Courts Discuss Unique Attributes of DWI cases Discuss “Ideal Participants” for DWI Courts Consider DWI Court workings Don’t drink and make signs Problem Solving Courts Problem Solving Courts a.k.a Collaborative Justice, Solution-Focused Courts Problem Solving Focus Team Approach to Decision Making Integration of ancillary services Judicial Supervision of Treatment Process and Proactive Role of Judge In and Out of Court Direct Interaction between Participants and Judge Community Outreach ~2,500 Drug Tx Courts in U.S. Adult Federal Juvenile District Drug Tx Campus Family Courts Tribal DWI Reentry 500 1,157 Problem-Solving Courts Re- entry Gambling Gun Child Community Supp Mental Truancy P-S Health Courts Integrated DV Tx Veteran Prosti- tution Home Parole less Vio. International Perspective on Problem-Solving Courts Australia Bermuda England Jamaica Canada Mauritius Scotland Wales Ireland Northern Ireland New Zealand Guam Cayman Islands N. Marianas Belgium Guam Netherlands Mexico Georgia Surinam Macedonia Israel Brazil Norway Problem Solving Considerations Changing Traditional Attitudes of Judges and other team members Changing Role Orientations of Judges and other team members Resource Constraints Time Constraints
    [Show full text]
  • Drug Court Review
    DRUG COURT REVIEW Volume IX, Issue 1 NATIONAL DRUG COURT INSTITUTE ALEXANDRIA, VIRGINIA DRUG COURT REVIEW VOLUME IX, ISSUE 1 EDITOR IN CHIEF Douglas B. Marlowe, JD, PhD ASSOCIATE EDITOR Carolyn D. Hardin, MPA MANAGING EDITOR Vanessa Cunningham West, MA PRODUCTION EDITOR Jennifer L. Carson EDITORIAL BOARD Steven Belenko, PhD Shannon M. Carey, PhD Fred L. Cheesman, PhD David S. Festinger, PhD Michael W. Finigan, PhD Cary E. Heck, PhD Scott Henggeler, PhD Matthew L. Hiller, PhD Judge Peggy F. Hora (Ret.) Robert Kirchner, PhD Judge William G. Meyer (Ret.) Randy Monchick, JD, PhD Roger H. Peters, PhD Michael Rempel, MA John Roman, PhD Lisa M. Shannon, PhD, MSW NATIONAL DRUG COURT INSTITUTE C. West Huddleston, III, Chief Executive Officer Carolyn D. Hardin, MPA., Senior Director 1029 N. Royal Street, Suite 201 Alexandria, Virginia 22314 Tel. (703) 575-9400, Fax (703) 575-9402 www.ndci.org | iii Copyright 2014, National Drug Court Institute The National Drug Court Institute (NDCI) is the Professional Ser- vices Branch of the National Association of Drug Court Professionals (NADCP). NDCI is grateful to the Bureau of Justice Assistance with- in the Office of Justice Programs at the U.S. Department of Justice for the support that made this publication possible. This project was supported by Grant No. 2012-DC-BX-K007 award- ed by the Bureau of Justice Assistance. The Bureau of Justice Assis- tance is a component of the Office of Justice Programs, which also includes the Bureau of Justice Statistics, the National Institute of Jus- tice, the Office of Juvenile Justice and Delinquency Prevention, the SMART Office, and the Office for Victims of Crime.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness Et Al
    USOO6264,917B1 (12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness et al. (45) Date of Patent: Jul. 24, 2001 (54) TARGETED ULTRASOUND CONTRAST 5,733,572 3/1998 Unger et al.. AGENTS 5,780,010 7/1998 Lanza et al. 5,846,517 12/1998 Unger .................................. 424/9.52 (75) Inventors: Jo Klaveness; Pál Rongved; Dagfinn 5,849,727 12/1998 Porter et al. ......................... 514/156 Lovhaug, all of Oslo (NO) 5,910,300 6/1999 Tournier et al. .................... 424/9.34 FOREIGN PATENT DOCUMENTS (73) Assignee: Nycomed Imaging AS, Oslo (NO) 2 145 SOS 4/1994 (CA). (*) Notice: Subject to any disclaimer, the term of this 19 626 530 1/1998 (DE). patent is extended or adjusted under 35 O 727 225 8/1996 (EP). U.S.C. 154(b) by 0 days. WO91/15244 10/1991 (WO). WO 93/20802 10/1993 (WO). WO 94/07539 4/1994 (WO). (21) Appl. No.: 08/958,993 WO 94/28873 12/1994 (WO). WO 94/28874 12/1994 (WO). (22) Filed: Oct. 28, 1997 WO95/03356 2/1995 (WO). WO95/03357 2/1995 (WO). Related U.S. Application Data WO95/07072 3/1995 (WO). (60) Provisional application No. 60/049.264, filed on Jun. 7, WO95/15118 6/1995 (WO). 1997, provisional application No. 60/049,265, filed on Jun. WO 96/39149 12/1996 (WO). 7, 1997, and provisional application No. 60/049.268, filed WO 96/40277 12/1996 (WO). on Jun. 7, 1997. WO 96/40285 12/1996 (WO). (30) Foreign Application Priority Data WO 96/41647 12/1996 (WO).
    [Show full text]
  • Clinical Inquiries
    CLINICAL INQUIRIES F ROM THE F AMILY P RACTICE I NQUIRIES N ETWORK What is the best way to evaluate patients with acute diarrhea. Using retrospective 6 acute diarrhea? reviews, Bauer and colleagues developed a pre- diction rule for cases of infectious diarrhea. The “modified 3-day rule” recommends stool cultures EVIDENCE-BASED ANSWER Limited evidence for patients with diarrhea beginning more than 3 delineates the relative probabilities of causes of acute days after hospitalization only when they fall into 1 diarrhea, typically defined as a diarrheal disease last- of the following groups: patients older than 65 ing 14 days or fewer, in the developed world. Viruses years with permanently altered organ function, (rotavirus, Norwalk, and other enteric viruses) are those with HIV or neutropenia, those hospitalized responsible for most cases. Stool culture helps to iden- during suspected nosocomial outbreaks, and those tify bacterial causes (Salmonella, Shigella, enterotoxic suspected of nondiarrheal manifestations of enteric Escherichia coli), especially in patients with fever and infection.6 When the modified rule was applied bloody stool. A modified 3-day rule (eg, performing prospectively, only 2 cases were missed. Both only Clostridium difficile toxin tests on low-risk patients were at risk for immunosuppression, patients who have been hospitalized for 3 or more although they did not strictly meet the modified cri- days) leads to a more rational use of stool cultures teria. Neither required treatment.6 without missing cases of clinically significant disease. (Grade of recommendation: D, based on limited stud- RECOMMENDATIONS FROM OTHERS The ies, reliance on expert opinion, and consensus.) Infectious Diseases Society of America’s practice guidelines for the evaluation and treatment of acute EVIDENCE SUMMARY More than 2 million cases diarrhea recommends that stool culture for bacteria of infectious diarrhea are documented in the United (including enterotoxic E coli) should be considered States annually.
    [Show full text]
  • Wayland Baptist University Annual Daapp
    Drug and Alcohol Abuse Prevention Program WAYLAND BAPTIST UNIVERSITY ANNUAL DAAPP TABLE OF CONTENTS INTRODUCTION 2 STANDARDS OF CONDUCT 2 SANCTIONS 3 LEGAL SANCTIONS 5 Federal Law 6 Alaska 8 Arizona 20 Hawaii 29 New Mexico 32 Oklahoma 53 Texas 81 HEALTH RISKS 108 Drugs 108 Alcohol 124 DRUG AND ALCOHOL COUNSELING OPTIONS 124 Alaska 125 Arizona 127 Hawaii 128 New Mexico 129 Oklahoma 130 Texas 130 ANNUAL NOTIFICATION OF DAAPP 135 BIENNIEL REVIEW OF DAAPP 135 1 WAYLAND BAPTIST UNIVERSITY ANNUAL DAAPP INTRODUCTION Wayland Baptist University joins with Universities and Colleges across the United States in an effort to provide education about and to prevent drug and alcohol use and abuse. The United States Congress passed and the President signed into law the Drug-Free Schools and Communities Act Amendments of 1989-Public Law 101-226 on December 12, 1989. This Act requires an institution of higher education to certify that it has adopted and instituted a program to prevent the unlawful possession, use or distribution of illicit drugs and alcohol by students, faculty, and staff. The conditions for meeting these certification requirements include the following provisions: 1. All institutions of higher education must provide annually, in writing, to faculty, staff, and students a statement declaring: a. Standards of conduct that prohibit unlawful possession, use, or distribution of illicit drugs and alcohol on University property or in connection with University activities; b. An institutional commitment to impose sanctions against students, faculty, and staff who violate such standards of conduct; c. Appropriate legal sanctions under local, state and federal law for the unlawful possession or distribution of illicit drugs and alcohol; d.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2010/0081713 A1 Sharma Et Al
    US 20100081713A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2010/0081713 A1 Sharma et al. (43) Pub. Date: Apr. 1, 2010 (54) COMPOSITIONS AND METHODS FOR (22) Filed: Mar. 18, 2009 TREATINGVIRAL INFECTIONS Related U.S. Application Data (75) Inventors: Geeta Sharma, Singapore (SG); (60) Provisional application No. 61/069,917, filed on Mar. Ralf Altmeyer, Singapore (SG); 19, 2008. Vishal Pendharker, Singapore (SG); Yu Chen, Singapore (SG); Publication Classification Michael Foley, Chestnut Hill, MA (51) Int. Cl. (US) A63L/35 (2006.01) A6II 3L/25 (2006.01) Correspondence Address: A63L/35 (2006.01) Gearhart Law LLC A6II 3/13 (2006.01) 4 Femdale Avenue A6IP3L/2 (2006.01) Chatham, NJ 07928 (US) (52) U.S. Cl. .......... 514/459; 514/529; 514/647: 514/662 (73) Assignee: CombinatoRx, (Singapore) Pte. (57) ABSTRACT Ltd. The present invention provides compositions, methods, and kits for treating or preventing a viral infection (e.g., an infec (21) Appl. No.: 12/406,716 tion caused by an influenza virus). Patent Application Publication Apr. 1, 2010 Sheet 1 of 2 US 2010/0081713 A1 ------ 80 r -0. Vehicle 0.5% HPMC g - - Sertraline-30mg/kg/day - £ 60 “A Sertraline-100mg/kg/day/kg/day i -v. Oseltamivir-30mg/kg/day ...i -0. Oseltamivir-100mg/kg/day -0. (Sertraline 30mg/kg+ . 40 Prednisolone 0.1 mg/Kg) Figure 1 Patent Application Publication Apr. 1, 2010 Sheet 2 of 2 US 2010/0081713 A1 100 468OOO 2 O Wehicle Sentraline 10 mg/kg Sentraline 30mg/kg Setraline 100mg/kg Figure 2 US 2010/008 1713 A1 Apr.
    [Show full text]
  • Court Intervention: Pre-Sentence Investigation
    If you have issues viewing or accessing this file contact us at NCJRS.gov. ------~--- ---- .. National Criminal Justice Reference Service COURT INTERVENTION: PRE-SENTENCE This microfiche was 'produced from documents received for inclusion in the NCJRS data base. Since NCJRS cannot exercise control over the physical condition of the documents submitted, INVESTIGATION the individual frame quality will vary. The resolution chart on this frame may be used to evaluate the document quality. TECHNIQUES FOR DRINKING/DRIVING OFFENSES 2 8 1.0 :; 11111 . 111111:~ W IIp·2 .2 W I.r.: I~ w: J:,i 14.0 ..,.I.::. u. - 1.1 tIl&.:.u - , == I 111111.25 11111·1.4 111111.6 I ! I MICROCOPY RESOLUTION TEST CHART NATIONAL BUREAU OF STANDARDS-1963-A .. ' ~ ...,.. '~'''';'''' ..' .. ~" - q P ARTI'CIPANT'S Microfil~ing proced~;~~~sed to create this fiche comply with & the standards set forth i1141CFR lOl-11.SD4. MANUAL Points of view or opinions stated in this document are those of the author(s) and do not represent the official U.S. Department of Transportation DATE FILMED ~ National Highway Traffic Safety Administration position or policies of the U. S. Department of Justice. Washington, D.C. 20590 '-, . ~ , .... ~ 1. _ .I. ' 1 9/04/81' " National Institute of Justice -;: .J.____ .... United States Department of Justice Washington, D. C. 2053<1 • , --~---.~--~. --- ~ I ! CONTENTS SEMINAR AGENDA iii ; - l AGENDA PRE-SENTENCE INVESTIGATION SEMINAR Day One 0900-1200 1. Introduction and Overview UNITS 1. Introduction and Overview 1 i: This unit covers: (a) introduction and administrative infor­ 2. The Problem Drinking Drive 9 mation, (b) information on DOT/NHTSA standards, (c) the genesis of the project, and (d) explanation of the ASAP 3.
    [Show full text]
  • Substance Abuse
    \1\A-10/PSA/93.10 ORIGINAL: ENGUSH DISTR.: GENERAL PROGRAMME ON SUBSTANCE ABUSE Approaches to Treatment of Substance Abuse WORLD HEALTH ORGANIZATION ABSTRACf The aim of this report is to provide an updated description of different methods used around the world to treat health problems associated with substance use. The scope of treatment approaches currently practised around the world is wide, ranging from traditional healing practices via mutual self-help groups, psychological/behavioural treatment to pharmacological treatment. Also included is a chapter on the generalist responses to alcohol and other drug problems and a chapter on the concept of harm minimization. Another aspect is a chapter on specific descriptors, which distinguishes different treatments from one another and provides economic means of describing them. Social and structural extra-treatment factors influencing the treatment process are also a subject described in this report. ©World Health Organization, 1993 This document is not a formal publication of the World Health Organization (WHO), and all rights are reserved by the Organization. The document may, however, be freely reviewed, abstracted, reproduced and translated in part or in whole, but not for sale nor for use in conjunction with commercial purposes. The views expressed in documents by named authors are solely the responsibility of those authors. ii CONTENTS page Acknowledgements . v Introduction . 1 I. Descriptors of Treatments . 3 11. Factors Influencing Treatment . 31 Ill. Generalist Responses to Alcohol and other Drug Problems . 53 IV. Pharmacological Treatment of Dependence on Alcohol and other Drugs: An Overview . 75 V. Psychological, Behavioural and Psychodynamic Treatments for Substance Abuse . 103 VI.
    [Show full text]
  • Welcome to the Hennepin County Adult DWI Court
    ADULT DWI COURT PROGRAM Participant Handbook Fourth Judicial District Adult DWI Court Team The Honorable John Holahan, Fourth Judicial District Court 300 South Sixth Street, C-8 Government Center Minneapolis, MN 55487 Phone: 612.348.6000 • Fax: 612.596.8730 Drafted: December 13, 2006 Revised November 11, 2008 elcome to the Fourth Judicial District Adult DWI Court. We are here to help and support you in your goal to never drink and drive again. Your participation W in the program is one step in helping to alleviate this serious legal and social problem in our society. If you sincerely see the need to change your lifestyle by maintaining a sober, crime-free existence, we are confident you will be a successful participant in this program. As we begin this journey together, I am hopeful that you will eventually come to realize, step-by-step, day-by-day, as you are completing this program, how your overall quality of life has improved. Honorable John Holahan Fourth Judicial District Judge 1 Table of Contents Introduction ..................................................................................................................................... 3 Program Rules ................................................................................................................................. 4 Cost of Program .............................................................................................................................. 5 Treatment ........................................................................................................................................
    [Show full text]